YXT

ralimetinib


Toggle HydrogenToggle Labels

Chemical Component Summary

Nameralimetinib
Synonyms(5P)-5-[2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-imidazo[4,5-b]pyridin-2-amine
Identifiers5-[2-~{tert}-butyl-4-(4-fluorophenyl)-1~{H}-imidazol-5-yl]-3-(2,2-dimethylpropyl)imidazo[4,5-b]pyridin-2-amine
FormulaC24 H29 F N6
Molecular Weight420.526
TypeNON-POLYMER
Isomeric SMILESCC(C)(C)Cn1c2c(ccc(n2)c3c(nc([nH]3)C(C)(C)C)c4ccc(cc4)F)nc1N
InChIInChI=1S/C24H29FN6/c1-23(2,3)13-31-20-17(28-22(31)26)12-11-16(27-20)19-18(14-7-9-15(25)10-8-14)29-21(30-19)24(4,5)6/h7-12H,13H2,1-6H3,(H2,26,28)(H,29,30)
InChIKeyXPPBBJCBDOEXDN-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count60
Chiral Atom Count0
Bond Count63
Aromatic Bond Count21

Drug Info: DrugBank

DrugBank IDDB11787 
NameRalimetinib
Groups investigational
DescriptionRalimetinib has been used in trials studying the treatment of Postmenopausal, Advanced Cancer, Adult Glioblastoma, Fallopian Tube Cancer, and Metastatic Breast Cancer, among others.
Synonyms
  • Ralimetinib Mesylate
  • Ralimetinib
CategoriesMitogen-Activated Protein Kinase 14, antagonists & inhibitors
CAS number862505-00-8

Related Resource References

Resource NameReference
PubChem 11539025
ChEMBL CHEMBL2364626